Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-28

Clinical Trial Update: Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

View source ↗

Summary

Clinical trial update describing a safety study of bevacizumab in combination with chemotherapy for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer | Status: UNKNOWN